Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8(+) Killer T Cells

Dendritic cells (DCs) are not targets for infection by the transforming Epstein-Barr virus (EBV). To test if the adjuvant role of DCs could be harnessed against EBV latency genes by cross-presentation, DCs were allowed to process either autologous or human histocompatibility leukocyte antigen (HLA)-...

Descripción completa

Detalles Bibliográficos
Autores principales: Subklewe, Marion, Paludan, Casper, Tsang, Ming L., Mahnke, Karsten, Steinman, Ralph M., Münz, Christian
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2001
Materias:
Brief Definitive Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195925/
https://www.ncbi.nlm.nih.gov/pubmed/11157061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195925/
https://www.ncbi.nlm.nih.gov/pubmed/11157061

Ejemplares similares